Stefano Portolano
Directeur Général chez Azafaros BV
Postes actifs de Stefano Portolano
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Azafaros BV
 Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | Directeur/Membre du Conseil | 30/06/2021 | - |
| Directeur Général | 30/06/2021 | - |
Historique de carrière de Stefano Portolano
Formation de Stefano Portolano
| Università degli Studi di Napoli Federico II | Doctorate Degree |
Statistiques
Internationale
| Pays-Bas | 2 |
| Italie | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | Health Technology |
- Bourse
- Insiders
- Stefano Portolano
- Expérience
